MONTREAL, CANADA--(Marketwire - October 31, 2007) - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that the United States Patent and Trademark Office has issued to ART patent number 7,286,869 entitled "Choice of wavelengths for multi-wavelength optical imaging". The use of this method within an optical medical imaging device allows significant improvement in the recovery of precise images of the physiological components. These components are used to provide indications for diagnosis and treatment monitoring of cancer in the ART SoftScan® optical breast imaging system.
